Importantly, we analyzed the survival difference between the altered and unaltered group of KCC2 (SLC12A5) and NKCC1 (SLC12A2) among cancer patients from 66 databases (Figure 9C and Supplementary Figure 2C). This evidence concerns the gene SLC12A5 and cancer.